The Utility of Advanced Cardiovascular Imaging in Cancer Patients—When, Why, How, and the Latest Developments

Cardio-oncology encompasses the risk stratification, prognostication, identification and management of cancer therapeutics related cardiac dysfunction (CTRCD). Cardiovascular imaging (CVI) plays a significant role in each of these scenarios and has broadened from predominantly quantifying left ventr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Christopher, Pathan, Faraz, Tan, Timothy C., Negishi, Kazuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446374/
https://www.ncbi.nlm.nih.gov/pubmed/34540922
http://dx.doi.org/10.3389/fcvm.2021.728215
_version_ 1784568856083169280
author Yu, Christopher
Pathan, Faraz
Tan, Timothy C.
Negishi, Kazuaki
author_facet Yu, Christopher
Pathan, Faraz
Tan, Timothy C.
Negishi, Kazuaki
author_sort Yu, Christopher
collection PubMed
description Cardio-oncology encompasses the risk stratification, prognostication, identification and management of cancer therapeutics related cardiac dysfunction (CTRCD). Cardiovascular imaging (CVI) plays a significant role in each of these scenarios and has broadened from predominantly quantifying left ventricular function (specifically ejection fraction) to the identification of earlier bio-signatures of CTRCD. Recent data also demonstrate the impact of chemotherapy on the right ventricle, left atrium and pericardium and highlight a possible role for CVI in the identification of CTRCD through tissue characterization and assessment of these cardiac chambers. This review aims to provide a contemporary perspective on the role of multi-modal advanced cardiac imaging in cardio-oncology.
format Online
Article
Text
id pubmed-8446374
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84463742021-09-18 The Utility of Advanced Cardiovascular Imaging in Cancer Patients—When, Why, How, and the Latest Developments Yu, Christopher Pathan, Faraz Tan, Timothy C. Negishi, Kazuaki Front Cardiovasc Med Cardiovascular Medicine Cardio-oncology encompasses the risk stratification, prognostication, identification and management of cancer therapeutics related cardiac dysfunction (CTRCD). Cardiovascular imaging (CVI) plays a significant role in each of these scenarios and has broadened from predominantly quantifying left ventricular function (specifically ejection fraction) to the identification of earlier bio-signatures of CTRCD. Recent data also demonstrate the impact of chemotherapy on the right ventricle, left atrium and pericardium and highlight a possible role for CVI in the identification of CTRCD through tissue characterization and assessment of these cardiac chambers. This review aims to provide a contemporary perspective on the role of multi-modal advanced cardiac imaging in cardio-oncology. Frontiers Media S.A. 2021-09-03 /pmc/articles/PMC8446374/ /pubmed/34540922 http://dx.doi.org/10.3389/fcvm.2021.728215 Text en Copyright © 2021 Yu, Pathan, Tan and Negishi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Yu, Christopher
Pathan, Faraz
Tan, Timothy C.
Negishi, Kazuaki
The Utility of Advanced Cardiovascular Imaging in Cancer Patients—When, Why, How, and the Latest Developments
title The Utility of Advanced Cardiovascular Imaging in Cancer Patients—When, Why, How, and the Latest Developments
title_full The Utility of Advanced Cardiovascular Imaging in Cancer Patients—When, Why, How, and the Latest Developments
title_fullStr The Utility of Advanced Cardiovascular Imaging in Cancer Patients—When, Why, How, and the Latest Developments
title_full_unstemmed The Utility of Advanced Cardiovascular Imaging in Cancer Patients—When, Why, How, and the Latest Developments
title_short The Utility of Advanced Cardiovascular Imaging in Cancer Patients—When, Why, How, and the Latest Developments
title_sort utility of advanced cardiovascular imaging in cancer patients—when, why, how, and the latest developments
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446374/
https://www.ncbi.nlm.nih.gov/pubmed/34540922
http://dx.doi.org/10.3389/fcvm.2021.728215
work_keys_str_mv AT yuchristopher theutilityofadvancedcardiovascularimagingincancerpatientswhenwhyhowandthelatestdevelopments
AT pathanfaraz theutilityofadvancedcardiovascularimagingincancerpatientswhenwhyhowandthelatestdevelopments
AT tantimothyc theutilityofadvancedcardiovascularimagingincancerpatientswhenwhyhowandthelatestdevelopments
AT negishikazuaki theutilityofadvancedcardiovascularimagingincancerpatientswhenwhyhowandthelatestdevelopments
AT yuchristopher utilityofadvancedcardiovascularimagingincancerpatientswhenwhyhowandthelatestdevelopments
AT pathanfaraz utilityofadvancedcardiovascularimagingincancerpatientswhenwhyhowandthelatestdevelopments
AT tantimothyc utilityofadvancedcardiovascularimagingincancerpatientswhenwhyhowandthelatestdevelopments
AT negishikazuaki utilityofadvancedcardiovascularimagingincancerpatientswhenwhyhowandthelatestdevelopments

Ejemplares similares